USPTO serial 79088593
NICTUR
Reviewed by CopyMark Law Group
Reg. 3964633Status 404
- Filing date
- Status date
- Registration date
- May 24, 2011
- Examiner
- MIDDLETON, BERNICE L
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with NICTUR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for human use, in particular for use in nighttime or daytime enuresis, Willebrand-Jurgen's syndrome, hemorrhaging, diabetes insipidus, for use in oncology, for treating cancer, for treating cardiovascular diseases, antivirals, for treating inflammatory diseases of the intestine, for treating inflammatory diseases of the connective tissue, for treating arthritis, for treating urological diseases, for treating psychiatric diseases, in particular mood disorders, anxiety disorders, cognitive disorders, schizophrenia, for treating neurological and neurodegenerative diseases and disorders, in particular, dementia linked to Alzheimer's disease, Huntington's disease, Parkinson's disease, cerebral palsy, brain injuries and diseases, injuries and diseases of the spinal cord, convulsive disorders, epilepsy, encephalitis, disorders of the central nervous system, ocular motility disorders, dystonia, blepharospasm, strabismus, facial scoliosis and tics, cerebral ischemia, dementia, amyotrophic sclerosis, and lateral multiple sclerosis, for treating auto-immune diseases, for treating transplant rejection, for treating ophthalmological diseases such as proliferative or non-proliferative diabetic retinopathy, macular degeneration, age-related macular degeneration, retinal neovascularization, neovascularization associated with choroidal melanoma, retinopathy, central retinal vein occlusion, pigmentary retinitis, uveitis, macular edema, cystoid macular edema, peptides | SECTION 70 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 19, 2020 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Jun 7, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 23, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Apr 13, 2018 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 15, 2017 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Dec 15, 2017 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Aug 14, 2015 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 2, 2011 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 2, 2011 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 2, 2011 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 23, 2011 | GPAR | GRANT OF PROTECTION CREATED, TO BE SENT TO IB | — |
| May 24, 2011 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 8, 2011 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 3, 2011 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 3, 2011 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Feb 16, 2011 | NPUB | NOTICE OF PUBLICATION | — |
| Jan 14, 2011 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 9, 2011 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 20, 2010 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 16, 2010 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 12, 2010 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Nov 11, 2010 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |